Skip to main navigation
Skip to search
Skip to main content
Manipal Academy of Higher Education, Manipal, India Home
Help & FAQ
Home
Profiles
Research units
Research output
Equipment
Search by expertise, name or affiliation
Restless legs syndrome: Pathophysiology and modern management
Kavitha Nagandla
*
, Somsubhra De
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
61
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Restless legs syndrome: Pathophysiology and modern management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
risks
100%
management
100%
dopamine
100%
patients
50%
recommendations
50%
pregnancy
50%
levels
25%
women
25%
drugs
25%
safety
25%
inflammation
25%
populations
25%
quality of life
25%
iron
25%
morbidity
25%
genetics
25%
central nervous system
25%
men
25%
motors
25%
augmentation
25%
refractories
25%
deregulation
25%
endorphins
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pathophysiology
100%
Restless Legs Syndrome
100%
Gabapentin
50%
Dopamine Receptor Stimulating Agent
41%
Opiate
33%
Rotigotine
16%
Gabapentin Enacarbil
16%
Pramipexole
16%
Levodopa
16%
Ropinirole
16%
Benzodiazepine
8%
Endorphin
8%
Prevalence
8%
Carbamazepine
8%
Neurologic Disease
8%
Tramadol
8%
Neurotransmitter
8%
Autonomic Dysfunction
8%
Motor Dysfunction
8%
Orexin
8%
Disease
8%
Transdermal Patch
8%
Pregabalin
8%
Cardiovascular Disease
8%
Neuroscience
Restless Legs Syndrome
100%
Gabapentin
50%
Dopamine Agonist
33%
Opiate
33%
Gabapentin Enacarbil
16%
Pramipexole
16%
Ropinirole
16%
Rotigotine
16%
L-DOPA
16%
Central Nervous System
8%
Dopaminergic
8%
Carbamazepine
8%
Neurotransmitter
8%
Tramadol
8%
Orexin
8%
Dysautonomia
8%
Pregabalin
8%
Neurological Disorder
8%
Benzodiazepine
8%
Endorphin
8%
Stereotypic Movement Disorder
8%
Anticonvulsant
8%
Immune System Disorders
8%